Melita Šalković‐Petrišić

Author

Also Known As

M SALKOVICPETRISIC, M Salkovic-Petrisic, M Šalković-Petrišić, M. Salkovic-Petrisic, M. Salkovic‐Petrisic, M. Šalković-Petrišić, M., Salkovic-Petrisic, Melita Salkovic-Petrisic, Melita Salkovic‐Petrisic, Melita Šalković-Petrišić

128

Publications

Citations

H-Index

Concepts

All Affiliations

University of Zagreb Universitätsklinikum Würzburg Heidelberg University University of Würzburg University of Southern Denmark

MŠ

About

Melita Šalković‐Petrišić is an author at University of Zagreb specializing in medicine, neuroscience, and alzheimer's disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	1K
2	Social Sciences	11	12	698
3	Biochemistry	3	3	108
4	Health Sciences	2	2	39
5	Biomedical Engineering	1	1	20

Melita Šalković‐Petrišić

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein Edna Grünblatt, Melita Šalković‐Petrišić, Jelena Osmanović Barilar, Journal of Neurochemistry	2007	377
Alzheimer‐like changes in protein kinase B and glycogen synthase kinase‐3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway Melita Šalković‐Petrišić, Florian Tribl, Manuela Schmidt, Journal of Neurochemistry	2006	220
Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer’s disease Ana Knezović, Jelena Osmanović Barilar, Marija Ćurlin, Journal of Neural Transmission Neurodegenerative DiseasesNeuropsychologyAlzheimer's DiseaseNeurobiology Of DiseaseMedicine	2015	149
Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer’s disease: a long-term follow up study Melita Šalković‐Petrišić, Jelena Osmanović Barilar, Martina K. Brückner, Journal of Neural Transmission Neurodegenerative DiseasesAlzheimer's DiseaseNeurobiology Of DiseaseCerebral Amyloid AngiopathyDementia	2011	139
Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: Bilateral effect after unilateral injection Lidija Bach‐Rojecky, Melita Šalković‐Petrišić, Zdravko Lacković European Journal of Pharmacology Experimental Diabetic NeuropathyPain SyndromePain MedicineMedicineDiabetes	2010	124
Insulin-Resistant Brain State after Intracerebroventricular Streptozotocin Injection Exacerbates Alzheimer-like Changes in Tg2576 AβPP-Overexpressing Mice Konstanze Plaschke, Juergen Kopitz, Markus D. Siegelin, Journal of Alzheimer s Disease Tg2576 Aβpp-overexpressing MiceTau ProteinSocial SciencesIntracerebroventricular Streptozotocin InjectionAlzheimer's Disease	2010	120
Long-term oral galactose treatment prevents cognitive deficits in male Wistar rats treated intracerebroventricularly with streptozotocin Melita Šalković‐Petrišić, Jelena Osmanović Barilar, Ana Knezović, Neuropharmacology NeuropsychologyNeurophysiologyNeuroanatomyMale Wistar RatsMedicine	2013	84
Nine-month follow-up of the insulin receptor signalling cascade in the brain of streptozotocin rat model of sporadic Alzheimer’s disease Jelena Osmanović Barilar, Ana Knezović, Edna Grünblatt, Journal of Neural Transmission Neurodegenerative DiseasesAlzheimer's DiseaseMedicineSporadic Alzheimer ’Neurology	2014	55
Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer’s disease? Ana Knezović, Alexander Loncar, Jan Homolak, Journal of Neural Transmission Neurodegenerative DiseasesNeurobiology Of DiseaseAlzheimer's DiseaseMedicineIntracerebroventricular Streptozotocin	2017	53
Glucagon-like peptide-1 mediates effects of oral galactose in streptozotocin-induced rat model of sporadic Alzheimer’s disease Ana Knezović, Jelena Osmanović Barilar, Ana Babić Perhoč, Neuropharmacology Neurodegenerative DiseasesAlzheimer's DiseaseBiochemistryMedicineGlycobiology	2018	53

Page 1